BioScrip, Inc. (NASDAQ:BIOS)

CAPS Rating: 2 out of 5

The Company provides pharmaceutical and pharmacy benefit management services.

Recs

0
Player Avatar franktejon (< 20) Submitted: 11/3/2010 6:03:48 AM : Outperform Start Price: $4.49 BIOS Score: +39.51

strong buy at $2.00

Report this Post Reply

Featured Broker Partners


Advertisement